Skip to main content Back to Top

ISMP Targeted Medication Safety Best Practices for Hospitals # 2 - Oral Methotrexate Safeguards

Broadcast Date: October 20, 2021


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast episode reviews the ISMP Targeted Medication Safety Best Practices for Hospitals #2 on oral methotrexate safeguards. Speakers will discuss one institution’s experiences with assuring that dosing is accurate in electronic systems when medication orders are entered and providing specific patient and/or family education for all oral methotrexate discharge orders.


Nicholas CritesNicholas Crites, Pharm.D., is currently Medication Safety Pharmacist Specialist at Nebraska Medicine in Omaha, NE. After graduating pharmacy school at the University of Nebraska Medical Center, he completed a PGY1 at Nebraska Medicine. Following residency training and before transitioning into his current role, Nicholas practiced as a clinical pharmacist in internal medicine and surgical services. He has been a member of the ASHP Medication Safety Section Advisory Group since 2020.

Stacie EthingtonStacie Ethington MSN, RN-BC is the Medication Safety Nurse Specialist at Nebraska Medicine. During her time at Nebraska Medicine she has provided care to cardiac patients and has served as a nurse educator. For the last five years she had been dedicated to medication safety and has led initiatives such as conversion to ENFit and implementation of IV pump interoperability. Other responsibilities include monitoring for safety trends and preparing the organization for implementation of best practices.


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.